Vitiligo is a chronic skin disorder characterised by lighter (hypochromic) or completely white (achromic) patches caused by a lack or absence of melanin. These patches, ranging from pink to milky white, usually have well-defined borders, often slightly darker than the surrounding normal skin, and are frequently distributed symmetrically on the body.
Vitiligo can appear at any age, in all skin types and in both sexes. It is a benign, painless and non-contagious condition, but it may significantly affect body image and quality of life. In some patients, it is associated with other autoimmune diseases such as thyroiditis, autoimmune gastritis or diabetes, which makes specialist evaluation essential.
Therapeutic perspectives
At MAVIT, treatment of vitiligo is tailored to disease extent and activity and may include:
• topical therapies (antioxidants, corticosteroids, agents that stimulate melanogenesis, high-protection sunscreens)
• targeted supplements containing antioxidants, when appropriate
• systemic therapies (oral corticosteroids or other immunomodulatory drugs in selected, more severe cases)
• phototherapy to stimulate melanocyte activity and repigmentation, always planned and monitored by a specialist
The goal is to stabilise the condition and encourage repigmentation when feasible, while also supporting patients from an aesthetic and psychological standpoint through structured, realistic treatment pathways.
For consultations, check-ups and treatments at our centers
